Skip to main content

MoneyWorks4Me

Caplin Point Laboratories informs about press release

24 Sep 2021 Evaluate

Caplin Point Laboratories has informed that it enclosed a press release titled ‘Caplin Point's CRO Amaris Clinical completes USFDA audit with nil observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..